Pharmacokinetics of Intravenous Lorazepam in Pediatric Patients with and without Status Epilepticus.

Authors

James M. Chamberlain, Children's National Medical Center, Washington, DCFollow
Edmund V. Capparelli, University of California, San Diego
Kathleen M. Brown, George Washington University
Cheryl W. Vance, University of California - Davis
Kathleen Lillis, SUNY at Buffalo
Prashant Mahajan, Wayne State University
Richard Lichenstein, University of Maryland - Baltimore
Rachel M. Stanley, University of Michigan - Ann ArborFollow
Colleen O. Davis, University of Rochester
Stephen Gordon, University of Rochester
Jill M. Baren, University of Pennsylvania
John N. van den Anker, George Washington UniversityFollow

Document Type

Journal Article

Publication Date

4-2012

Journal

Journal of Pediatrics

Volume

Volume 160, Issue 4

Inclusive Pages

667-672.e2

Keywords

Lorazepam--pharmacokinetics; Status Epilepticus--metabolism

Comments

This is an open access PubMed Central article. Click on link for full-text access.

APA Citation

Chamberlain, J. M., Capparelli, E. V., Brown, K. M., Vance, C. W., Lillis, K., Mahajan, P., . . . Van Den Anker, J. N. (2012). Pharmacokinetics of intravenous lorazepam in pediatric patients with and without status epilepticus. Journal of Pediatrics, 160(4), 667-672.e2.

Peer Reviewed

1

Open Access

1